Niagen Bioscience, Inc.
NAGE
$6.53
$0.132.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,275.69% | 1,411.32% | 499.80% | 273.15% | 122.95% |
| Total Depreciation and Amortization | -5.41% | -23.55% | -35.04% | -42.35% | -44.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -109.80% | -129.21% | -133.90% | -109.64% | -24.75% |
| Change in Net Operating Assets | 116.75% | 204.64% | 406.51% | -31.30% | -161.01% |
| Cash from Operations | 412.77% | 1,871.28% | 326.34% | 70.14% | -32.00% |
| Capital Expenditure | -126.09% | -177.00% | -57.14% | -10.14% | 61.54% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | 300.00% | 300.00% | 300.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -173.68% | -157.00% | -44.09% | 0.00% | 67.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -20.00% | -33.33% | 35.29% | 26.67% | 50.00% |
| Issuance of Common Stock | 558.68% | 1,856.52% | -- | -- | -78.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.37% | 38.37% | 45.35% | 30.67% | -38.71% |
| Cash from Financing | 595.40% | 2,213.12% | 8,340.78% | 6,065.56% | -79.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 466.97% | 2,103.45% | 534.06% | 151.82% | -58.37% |